REGISTERED
on 02 Mar 2021
Last Applicant/ Owned by
1035 Cambridge Street, Suite 17B
Cambridge
MA
02141
Serial Number
88933620 filed on 26th May 2020
Registration Number
6280633 registered on 02th Mar 2021
Correspondent Address
Rachelle A. Dubow, Esq.
Filing Basis
1. use application currently
Disclaimer
NO DATA
ERIGEN
Pharmaceutical research and development services in the field of production of cell therapies, with or without gene-editing and with or without mRNA engineering; pharmaceutical research and development services, in the field of gene-editing, mRNA engineering, cell reprogramming, and cell therapy development
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development services in the field of production of cell therapies, with or without gene-editing and with or without mRNA engineering; pharmaceutical research and development services, in the field of gene-editing, mRNA engineering, cell reprogramming, and cell therapy development
First Use Date in General
31st May 2014
First Use Date in Commerce
31st May 2014
Mark Details
Serial Number
No 88933620
Mark Type
No Service Mark
Attorney Docket Number
No 107541-0038
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Mar 2021 | REGISTERED-PRINCIPAL REGISTER |
| 15th Dec 2020 | PUBLISHED FOR OPPOSITION |
| 15th Dec 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 25th Nov 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 12th Nov 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 12th Nov 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 12th Nov 2020 | EXAMINER'S AMENDMENT ENTERED |
| 12th Nov 2020 | EXAMINERS AMENDMENT -WRITTEN |
| 12th Nov 2020 | EXAMINERS AMENDMENT E-MAILED |
| 28th Aug 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |